Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Trastuzumab BS
- Status
- COMPLETED
- Phase
- N/A
Copenhagen, Boston, Sydney
- Status
- COMPLETED
- Phase
- NA
Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy
- Status
- COMPLETED
- Phase
- N/A
Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project
- Status
- COMPLETED
- Phase
- N/A
Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
Talazoparib and Thoracic RT for ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In Portugal
- Status
- WITHDRAWN
- Phase
- N/A
Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)
- Status
- COMPLETED
- Phase
- N/A
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
Study of Single Ascending Doses of PF-07081532 in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants
- Status
- COMPLETED
- Phase
- PHASE1
Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1